Immaculate Nankya

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

Raph L Hamers, Carole L. Wallis, Cissy Kityo et al. · The Lancet Infectious Diseases · 2011 · 289 citations

Epidemiology, Antiretroviral Therapy, Hiv/aids Counselling +12

Relation Between Chemokine Receptor Use, Disease Stage, and HIV-1 Subtypes A and D

Pontiano Kaleebu, Immaculate Nankya, David Yirrell et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 116 citations

CCR5- and CXCR4-Tropic Subtype C Human Immunodeficiency Virus Type 1 Isolates Have a Lower Level of Pathogenic Fitness than Other Dominant Group M Subtypes: Implications for the Epidemic

Awet Abraha, Immaculate Nankya, Richard M. Gibson et al. · Journal of Virology · 2009 · 103 citations · Full text

HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle?

Denis M. Tebit, Immaculate Nankya, Eric J. Arts et al. · PubMed · 2007 · 100 citations

Disease Progression, Fitness, Genetics +18

Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa

T. Sonia Boender, Cissy Kityo, Ragna S. Boerma et al. · Journal of Antimicrobial Chemotherapy · 2016 · 96 citations · Full text